Literature DB >> 31740787

NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.

Prashant V Bommi1,2, Vaibhav Chand3, Nishit K Mukhopadhyay3, Pradip Raychaudhuri4, Srilata Bagchi5.   

Abstract

Cancers in the oral/head & neck region (HNSCC) are aggressive due to high incidence of recurrence and distant metastasis. One prominent feature of aggressive HNSCC is the presence of severely hypoxic regions in tumors and activation of hypoxia-inducible factors (HIFs). In this study, we report that the XPE gene product DDB2 (damaged DNA binding protein 2), a nucleotide excision repair protein, is upregulated by hypoxia. Moreover, DDB2 inhibits HIF1α in HNSCC cells. It inhibits HIF1α in both normoxia and hypoxia by reducing mRNA expression. Knockdown of DDB2 enhances the expression of angiogenic markers and promotes tumor growth in a xenograft model. We show that DDB2 binds to an upstream promoter element in the HIF1Α gene and promotes histone H3K9 trimethylation around the binding site by recruiting Suv39h1. Also, we provide evidence that DDB2 has a significant suppressive effect on expression of the endogenous markers of hypoxia that are also prognostic indicators in HNSCC. Together, these results describe a new mechanism of hypoxia regulation that opposes expression of HIF1Α mRNA and the hypoxia-response genes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31740787     DOI: 10.1038/s41388-019-1105-y

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

Review 1.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

Review 2.  Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies.

Authors:  Hua Sui; Lei Zhu; Wanli Deng; Qi Li
Journal:  Oncol Res Treat       Date:  2014-09-16       Impact factor: 2.825

Review 3.  Role of integrated cancer nanomedicine in overcoming drug resistance.

Authors:  Arun K Iyer; Amit Singh; Srinivas Ganta; Mansoor M Amiji
Journal:  Adv Drug Deliv Rev       Date:  2013-07-21       Impact factor: 15.470

Review 4.  Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy.

Authors:  P Vaupel; D K Kelleher; M Höckel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

Review 5.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.

Authors:  G L Semenza
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

6.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.

Authors:  N V Iyer; L E Kotch; F Agani; S W Leung; E Laughner; R H Wenger; M Gassmann; J D Gearhart; A M Lawler; A Y Yu; G L Semenza
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

Review 7.  Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications.

Authors:  P Vaupel; Susanne Briest; M Höckel
Journal:  Wien Med Wochenschr       Date:  2002

8.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Authors:  G L Wang; B H Jiang; E A Rue; G L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 9.  The role of oxygen availability in embryonic development and stem cell function.

Authors:  M Celeste Simon; Brian Keith
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02-20       Impact factor: 94.444

Review 10.  Hypoxia-inducible factors, stem cells, and cancer.

Authors:  Brian Keith; M Celeste Simon
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

View more
  6 in total

Review 1.  A protein with broad functions: damage-specific DNA-binding protein 2.

Authors:  Ning Bao; Jiguang Han; Huimin Zhou
Journal:  Mol Biol Rep       Date:  2022-10-03       Impact factor: 2.742

2.  MiR-935/HIF1α Feedback Loop Inhibits the Proliferation and Invasiveness of Glioma.

Authors:  Guangjing Huang; Jie Chen; Jing Liu; Xiaoyan Zhang; Haijie Duan; Qian Fang
Journal:  Onco Targets Ther       Date:  2020-10-23       Impact factor: 4.147

3.  Increased PPARD Expression May Play a Protective Role in Human Lung Adenocarcinoma and Squamous Cell Carcinoma.

Authors:  Yong Zhu; Yedong Mi; Zhonghua Qin; Xuewei Jiang; Yibo Shan; Kamil Kural; Guiping Yu
Journal:  PPAR Res       Date:  2022-03-15       Impact factor: 4.964

4.  The E2F1 transcription factor and RB tumor suppressor moonlight as DNA repair factors.

Authors:  Swarnalatha Manickavinayaham; Renier Velez-Cruz; Anup K Biswas; Jie Chen; Ruifeng Guo; David G Johnson
Journal:  Cell Cycle       Date:  2020-08-13       Impact factor: 4.534

Review 5.  Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis.

Authors:  Nerina Denaro; Marco Carlo Merlano; Cristiana Lo Nigro
Journal:  Cancer Manag Res       Date:  2021-05-17       Impact factor: 3.989

6.  MEKK1-Dependent Activation of the CRL4 Complex Is Important for DNA Damage-Induced Degradation of p21 and DDB2 and Cell Survival.

Authors:  Susanne Bacher; Hilda Stekman; Carla M Farah; Annika Karger; Michael Kracht; M Lienhard Schmitz
Journal:  Mol Cell Biol       Date:  2021-07-12       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.